(Q38620000)

4 September 2017

Advancing cell wall inhibitors towards clinical applications (English)

1 reference

4 September 2017

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26515981%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

Sonia I Maffioli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26515981%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

João C S Cruz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26515981%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Paolo Monciardini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26515981%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Stefano Donadio

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26515981%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

publication date

29 October 2015

1 reference

Journal of Industrial Microbiology & Biotechnology

4 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26515981%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26515981%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26515981%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

page(s)

177-184

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26515981%20AND%20SRC:MED&resulttype=core&format=json

Phosphate-controlled regulator for the biosynthesis of the dalbavancin precursor A40926.

6 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10295-015-1703-9

Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10295-015-1703-9

Lipid II as a target for antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10295-015-1703-9

Bacterial cell wall assembly: still an attractive antibacterial target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10295-015-1703-9

Brominated Variant of the Lantibiotic NAI-107 with Enhanced Antibacterial Potency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10295-015-1703-9

Lantibiotics: promising candidates for future applications in health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10295-015-1703-9

L-form bacteria, cell walls and the origins of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10295-015-1703-9

A Derivative of the Thiopeptide GE2270A Highly Selective against Propionibacterium acnes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10295-015-1703-9

Microbisporicin gene cluster reveals unusual features of lantibiotic biosynthesis in actinomycetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10295-015-1703-9

A glycosylated, labionin-containing lanthipeptide with marked antinociceptive activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10295-015-1703-9

Efficacy of the new lantibiotic NAI-107 in experimental infections induced by multidrug-resistant Gram-positive pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10295-015-1703-9

Pharmacological properties of NAI-603, a well-tolerated semisynthetic derivative of ramoplanin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10295-015-1703-9

Strategies for the isolation and characterization of antibacterial lantibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10295-015-1703-9

Glycopeptide and lipoglycopeptide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10295-015-1703-9

New strategies and methods in the discovery of natural product anti-infective agents: the mannopeptimycins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10295-015-1703-9

In vivo pharmacokinetics and pharmacodynamics of the lantibiotic NAI-107 in a neutropenic murine thigh infection model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10295-015-1703-9

A new antibiotic kills pathogens without detectable resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10295-015-1703-9

Two Master Switch Regulators Trigger A40926 Biosynthesis in Nonomuraea sp. Strain ATCC 39727.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10295-015-1703-9

Family of class I lantibiotics from actinomycetes and improvement of their antibacterial activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10295-015-1703-9

Structure revision of the lantibiotic 97518.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10295-015-1703-9

Discovering new bioactive molecules from microbial sources.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10295-015-1703-9

Lipodepsipeptide empedopeptin inhibits cell wall biosynthesis through Ca2+-dependent complex formation with peptidoglycan precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10295-015-1703-9

The Lantibiotic NAI-107 Binds to Bactoprenol-bound Cell Wall Precursors and Impairs Membrane Functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10295-015-1703-9

Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10295-015-1703-9

An oldie but a goodie - cell wall biosynthesis as antibiotic target pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10295-015-1703-9

Improved production of A40926 by Nonomuraea sp. through deletion of a pathway-specific acetyltransferase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10295-015-1703-9

The gene cluster for the biosynthesis of the glycopeptide antibiotic A40926 by nonomuraea species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10295-015-1703-9

Chemistry and biology of ramoplanin: a lipoglycodepsipeptide with potent antibiotic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10295-015-1703-9

Origin, structure, and activity in vitro and in vivo of dalbavancin

21 January 2018

1 reference

12 December 2020

Synthesis and preliminary biological characterization of new semisynthetic derivatives of ramoplanin

1 reference

12 December 2020

Distinct mechanisms contribute to immunity in the lantibiotic NAI-107 producer strain Microbispora ATCC PTA-5024

1 reference

12 December 2020

Characterization of the congeners in the lantibiotic NAI-107 complex

1 reference

12 December 2020

Isolation and characterization of NAI-802, a new lantibiotic produced by two different Actinoplanes strains

1 reference

12 December 2020

Synthesis and biological activity of some amide derivatives of the lantibiotic actagardine.

1 reference

12 December 2020

New semisynthetic glycopeptides MDL 63,246 and MDL 63,042, and other amide derivatives of antibiotic A-40,926 active against highly glycopeptide-resistant VanA enterococci.

1 reference

12 December 2020

10.1007/S10295-015-1703-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26515981%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

1 reference